Nephros (NEPH) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.56% |
| Dec 31, 2025 | -150.14% |
| Sep 30, 2025 | -98.51% |
| Jun 30, 2025 | -76.74% |
| Mar 31, 2025 | -23.26% |
| Dec 31, 2024 | 1.37% |
| Sep 30, 2024 | 16.99% |
| Jun 30, 2024 | 16.15% |
| Mar 31, 2024 | 10.75% |
| Dec 31, 2023 | 6.08% |
| Sep 30, 2023 | -30.02% |
| Jun 30, 2023 | -0.50% |
| Mar 31, 2023 | 13.48% |
| Dec 31, 2022 | 33.10% |
| Sep 30, 2022 | 7.90% |
| Jun 30, 2022 | 11.26% |
| Mar 31, 2022 | -53.03% |
| Dec 31, 2021 | -35.34% |
| Sep 30, 2021 | -22.34% |
| Jun 30, 2021 | -14.12% |
| Mar 31, 2021 | -40.43% |
| Dec 31, 2020 | -32.91% |
| Sep 30, 2020 | -131.28% |
| Jun 30, 2020 | -133.05% |
| Mar 31, 2020 | -92.98% |
| Dec 31, 2019 | -56.25% |
| Sep 30, 2019 | -0.68% |
| Jun 30, 2019 | 6.87% |
| Mar 31, 2019 | 5.61% |
| Dec 31, 2018 | -8.20% |
| Sep 30, 2018 | -8.97% |
| Jun 30, 2018 | -50.22% |
| Mar 31, 2018 | -71.31% |
| Dec 31, 2017 | -19.91% |
| Dec 31, 2016 | 19.50% |
| Mar 31, 2016 | -43.83% |
| Dec 31, 2015 | -163.78% |
| Sep 30, 2015 | -70.47% |
| Jun 30, 2015 | -1.66% |
| Mar 31, 2015 | 44.73% |
| Dec 31, 2014 | 8.75% |
| Dec 31, 2013 | -34.12% |